Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $9.7400 (0.83%) ($9.6800 - $10.6300) on Fri. Jun. 5, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 9.22% (three month average) | RSI | 51 | Latest Price | $9.7400(0.83%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -3.3% a day on average for past five trading days. | Weekly Trend | ATRA declines -9.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(46%) IBB(45%) ARKK(44%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -4.61% in a week (0% probabilities). VIXM(-32%) VXX(-28%) UNG(-10%) UUP(-9%) TLT(-8%) | | | | | Relative Volatility | | | | Market Trend Strength | -4.61% (StdDev 9.22%) | Hourly BBV | 0 () | Intraday Trend | -3% | | | |
|
Resistance Level | $11.23 | 5 Day Moving Average | $10.3(-5.44%) | 10 Day Moving Average | $11.08(-12.09%) | 20 Day Moving Average | $11.23(-13.27%) | To recent high | -34.8% | To recent low | 71.2% | Market Cap | $724m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |